Krystal Biotech (KRYS) Shares Outstanding (Diluted Average) (2020 - 2026)

Krystal Biotech's Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $30.5 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 2.13% year-over-year to $30.5 million; the TTM figure through Mar 2026 stood at $30.5 million (up 2.13% YoY), while the FY2025 annual figure was $30.0 million, up 0.71% from the prior year.
• Shares Outstanding (Diluted Average) came in at $30.5 million for Q1 2026 at Krystal Biotech, up from $30.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $30.5 million in Q1 2026 to a low of $25.1 million in Q1 2022.
• A 5-year average of $28.1 million and a median of $29.3 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• Across the five-year window, Shares Outstanding (Diluted Average) gained 18.17% in 2022 and rose 0.55% in 2025, its largest moves.
• Krystal Biotech's Shares Outstanding (Diluted Average) stood at $25.5 million in 2022, then climbed by 8.87% to $27.8 million in 2023, then advanced by 7.16% to $29.7 million in 2024, then grew by 0.71% to $30.0 million in 2025, then advanced by 1.86% to $30.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $30.5 million, $30.0 million, and $29.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison